These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7753711)

  • 1. Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells.
    Reyes-Moreno C; Frenette G; Boulanger J; Lavergne E; Govindan MV; Koutsilieris M
    Prostate; 1995 May; 26(5):260-9. PubMed ID: 7753711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton.
    Reyes-Moreno C; Koutsilieris M
    Clin Exp Metastasis; 1997 May; 15(3):205-17. PubMed ID: 9174122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG-63 human osteosarcoma cells.
    Boulanger J; Reyes-Moreno C; Koutsilieris M
    Int J Cancer; 1995 May; 61(5):692-7. PubMed ID: 7768643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
    Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of glucocorticoid receptor transactivity and cell growth inhibition by transforming growth factor-beta through AP-1-mediated transcriptional repression.
    Periyasamy S; Sánchez ER
    Int J Biochem Cell Biol; 2002 Dec; 34(12):1571-85. PubMed ID: 12379279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.
    Nishimura K; Nonomura N; Satoh E; Harada Y; Nakayama M; Tokizane T; Fukui T; Ono Y; Inoue H; Shin M; Tsujimoto Y; Takayama H; Aozasa K; Okuyama A
    J Natl Cancer Inst; 2001 Nov; 93(22):1739-46. PubMed ID: 11717335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145.
    Dondi D; Maggi R; Scaccianoce E; Martini L; Motta M; Poletti A
    J Mol Endocrinol; 2001 Jun; 26(3):185-91. PubMed ID: 11357055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid up-regulates transforming growth factor-beta (TGF-beta) type II receptor and enhances TGF-beta signaling in human prostate cancer PC-3 cells.
    Li Z; Chen Y; Cao D; Wang Y; Chen G; Zhang S; Lu J
    Endocrinology; 2006 Nov; 147(11):5259-67. PubMed ID: 16887915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
    Franzén P; Ichijo H; Miyazono K
    Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids, TGF-beta, and embryonic mouse salivary gland morphogenesis.
    Jaskoll T; Choy HA; Melnick M
    J Craniofac Genet Dev Biol; 1994; 14(4):217-30. PubMed ID: 7883868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
    Rowley DR; Dang TD; McBride L; Gerdes MJ; Lu B; Larsen M
    Cancer Res; 1995 Feb; 55(4):781-6. PubMed ID: 7850789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines.
    Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A
    J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):29-36. PubMed ID: 19406240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
    Bang YJ; Kim SJ; Danielpour D; O'Reilly MA; Kim KY; Myers CE; Trepel JB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3556-60. PubMed ID: 1373503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
    Goya L; Maiyar AC; Ge Y; Firestone GL
    Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
    Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
    Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells.
    Tenta R; Sourla A; Lembessis P; Luu-The V; Koutsilieris M
    Horm Metab Res; 2005 Oct; 37(10):593-601. PubMed ID: 16278781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest.
    Zuo Z; Urban G; Scammell JG; Dean NM; McLean TK; Aragon I; Honkanen RE
    Biochemistry; 1999 Jul; 38(28):8849-57. PubMed ID: 10413457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.